Spark Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Spark Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$151.91 - $192.21 $1.35 Million - $1.71 Million	-8,900 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$167.73 - $192.74 $687,693 - $790,234	4,100 Added 85.42%	8,900 $1.72 Million
Q2 2018 Aug 08, 2018	SELL	$145.72 - $169.96 $1.5 Million - $1.75 Million	-10,300 Reduced 68.21%	4,800 $815,000
Q1 2018 May 10, 2018	SELL	$151.6 - $177.13 $5.67 Million - $6.62 Million	-37,400 Reduced 71.24%	15,100 $2.46 Million
Q4 2017 Feb 12, 2018	SELL	$137.28 - $155.55 $3.51 Million - $3.98 Million	-25,600 Reduced 32.78%	52,500 $7.87 Million
Q3 2017 Nov 13, 2017	BUY	$148.13 - $162.24 $11.6 Million - $12.7 Million	78,100	78,100 $11.9 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.